~ If Approved by the FDA, PEDMARK Stands to Be the First Therapy for the Prevention of Cisplatin-Induced Hearing Loss in Children ~ Research Triangle Park, NC, May 28 , 2021 – Fennec Pharmaceu ticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced the